Renal cell carcinoma (RCC) diagnosis is mostly achieved incidentally by imaging provided for unrelated clinical reasons. The surgical management of localized tumors has reported excellent results. The therapy of advanced RCC has evolved considerably over recent years with the widespread use of the so-called “targeted therapies.” The identification of molecular markers in body fluids (e.g., sera and urine), which can be used for screening, diagnosis, follow-up, and monitoring of drug-based therapy in RCC patients, is one of the most ambitious challenges in oncologic research. Although there are some promising reports about potential biomarkers in sera, there is limited available data regarding urine markers for RCC. The following review reports some of the most promising biomarkers identified in the biological fluids of RCC patients.

Serum and urine biomarkers for human renal cell carcinoma / Pastore, ANTONIO LUIGI; Palleschi, Giovanni; Silvestri, Luigi; D., Moschese; S., Ricci; Petrozza, Vincenzo; Carbone, Antonio; DI CARLO, Angelina. - In: DISEASE MARKERS. - ISSN 0278-0240. - STAMPA. - 2015:(2015), pp. 1-9. [10.1155/2015/251403]

Serum and urine biomarkers for human renal cell carcinoma

PASTORE, ANTONIO LUIGI;PALLESCHI, GIOVANNI;SILVESTRI, LUIGI;PETROZZA, Vincenzo;CARBONE, Antonio;DI CARLO, ANGELINA
2015

Abstract

Renal cell carcinoma (RCC) diagnosis is mostly achieved incidentally by imaging provided for unrelated clinical reasons. The surgical management of localized tumors has reported excellent results. The therapy of advanced RCC has evolved considerably over recent years with the widespread use of the so-called “targeted therapies.” The identification of molecular markers in body fluids (e.g., sera and urine), which can be used for screening, diagnosis, follow-up, and monitoring of drug-based therapy in RCC patients, is one of the most ambitious challenges in oncologic research. Although there are some promising reports about potential biomarkers in sera, there is limited available data regarding urine markers for RCC. The following review reports some of the most promising biomarkers identified in the biological fluids of RCC patients.
2015
independent prognostic-factor; gelatinase-associated lipocalin; gamma-glutamyl-transferase; carbonic-anhydrase ix; lymph-node dissection; kidney cancer; surgical-management; radical nephrectomy; factor receptor; tumors
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Serum and urine biomarkers for human renal cell carcinoma / Pastore, ANTONIO LUIGI; Palleschi, Giovanni; Silvestri, Luigi; D., Moschese; S., Ricci; Petrozza, Vincenzo; Carbone, Antonio; DI CARLO, Angelina. - In: DISEASE MARKERS. - ISSN 0278-0240. - STAMPA. - 2015:(2015), pp. 1-9. [10.1155/2015/251403]
File allegati a questo prodotto
File Dimensione Formato  
Pastore_Serum-urine-biomarkers_2015.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 1.23 MB
Formato Adobe PDF
1.23 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/780397
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 46
  • ???jsp.display-item.citation.isi??? 43
social impact